##  [RAD001 Shows Potential to Reverse Resistance to Herceptin®\* in Metastatic Breast Cancer Patients, Leading to Phase III Trial](/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0 "RAD001 Shows Potential to Reverse Resistance to Herceptin®* in Metastatic Breast Cancer Patients, Leading to Phase III Trial") 

  Dec 12, 2008